biofab europe 2016
TRANSCRIPT
www.biofab.com.pe
USA–Chile-PeruMexico-TheNetherlands
ReducingorgantransplantaBonwaiBnglistsbyprovidingbio-generatedorgans
ABOUTUSCesarLoo–FounderGaby–Co-FounderRicardoGarcia–InternaBonalPR
ApaBentwaiBngforanorganTime-Stress-Pain
PROBLEM
ReducingorgantransplantaBonwaiBnglistsbyprovidingbio-generatedorgans
OURCOREPURPOSE
OBSTACLE
HIGHCOSTCOMPATIBLEORGANBLOODTYPE
STRATEGY
BUSINESSMODELS
BankofOrgan-CryopreservaBonofumbilicalcordstemcells,adiposeBssueandthethirdmolar.DifferenBaBonandmulBplicaBonofstemcellsClassesforprotocolsofextracBon,differenBaBon,cryopreservaBonandstemcellapplicaBon.BioPrinterBiofabsales.
3dPrinterStemCellTechnology
Organtransplant
1.Umbilicalcord2.Thirdmolarandbabyteeth3.AdiposeBssue
Umbilicalcord
LowCost
3dPrinterStemCellTechnology
COMPETITORS
BiofabwillincreasehumanlifeduraBon 44100diewhileofficiallyplacedonthesewaiBnglists
PLACEDONORGAN
WAITINGLIST
waitforaneworgantransplanta/on
263,000peopleinEurope
Sellorgans:traquea,esophagus,bladderKit:Bioprinter,biogel,stemcells,bioreactor
LEARNEDATBRIGHTLANDSINNOVATIONFACTORY
UniversityofMaastricht–Dr.LorenzoMoroni,ProfessorinBiofabricaBonNoviocell–PhDJulie^eVandenDolder
VALIDATION
THEOPPORTUNITY
StarBngacompany(BV)inTheNethetlands,atBrightlandstohavetheoperaBoncenterforEurope
AgreementUPCH
MulBdentHospitalesAngeles
Today
ScaleChileMexicoUSA
WorldTourShowBioPrinterinTechFairs
Oct2016
FirstTransplantEsophagusTransplantinHuman
Nov-20162014
2015
2016
ROADMAP
2017
28%
42%
21%9%
MarkeBng Team
UseSalesCurrentlySales$205,000.00[Customers]
• 200Clients• 57CriopreservatesStemCells• 03AgreementswithUniversiBes
AchievementstoDate
• IncorporateBioFabinUSA.BioFabInc
• 1Patent
• IncorporatedBioFabinPeru,Chile,MexicoandTheNetherlands
• BioPrinterFinalVersion
• 3OrdesBioPrintersinRusia,CanadaandThailand
TRACTION
ReducingorgantransplantaBonwaiBnglists,byprovidingbiogeneratedorgans
THANKYOUForyourA^enBon